杭州Sciwind生物科技公司与辉瑞中国已正式签署战略合作协议,共同推进新一代Ecnoglutide注射剂的商业化进程。此次合作旨在整合双方在研发与市场渠道方面的优势,加速该创新药物在中国市场的应用与推广。
杭州Sciwind生物科技公司与辉瑞中国已正式签署战略合作协议,共同推进新一代Ecnoglutide注射剂的商业化进程。此次合作旨在整合双方在研发与市场渠道方面的优势,加速该创新药物在中国市场的应用与推广。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.